Abstract
The tachykinins, substance P (SP), neurokinin A (NKA), neuropeptide γ (NPγ) and neuropeptide K (NPK) are encoded by the single copy preprotachykinin A (PPT-A) gene on chromosome 7. Four tachykinin precursors (α-, β-, γ- and δ-PPT-A) arise from this gene by an alternative RNA splicing mechanism. The preprotachykinin B gene on chromosome 12 encodes the precursor of neurokinin B (NKB). The preprotachykinin C gene on chromosome 17 encodes a protein that contains the sequence of hemokinin 1(HK-1) and two peptides with limited structural similarity to SP,termed endokinin C and endokinin D. The actions of the tachykinins are mediated through activation of the NK1, NK2 and NK3 receptors. However, NH2-terminal fragments of SP such as SP (1–7) exert behavioral and other effects when administered centrally that appear not to be mediated through direct interaction with these receptors. Analogs of SP such as [Sar9]SP sulfone, and peptidase-resistant agonists such as GR73632, show greater potency and selectivity than SP for the NK1 receptor. Septide {[pGlu6,Pro9SP(6–11)}, although a poor competitor for radiolabeled SP in ligand binding assays, is a potent and selective agonist in many functional assays that involve activation of NK1 receptors. Septide is believed to bind to a distinct ‘septide sensitive’ site on the NK1 receptor. Analogs such as [Lys5,MeLeu9,Nle10] NKA(4–10) and [βAla8]NKA(4–10) show higher affinity and selectivity than NKA for the NK2 receptor and [MePhe7]NKB and senktide {succinyl-[Asp6, MePhe8]SP(6-11)} are more selective than NKB for the NK3 receptor. NPK and NPγ are preferred agonists for the NK2 receptor. The NH2 terminal extension to the NKA sequence in these tachykinins has only minor effects on potency in vitro but the greater stability of these agonists in vivo results in a different spectrum of activities. The physiological role of HK-1 remains to be firmly established but the peptide has a pharmacological profile similar to that of SP. Endokinins C and D display only very weak tachykinin-like bioactivity. Orthologs of the mammalian tachykinins have been isolated from the tissues of nonmammalian vertebrates ranging from birds to lampreys and analysis of their amino acid sequences and properties gives insight into structure-activity relationships.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Achapu M, Pompei P, Polidori C, de Caro G, Massi M (1992) Central effects of neuropeptide K on water and food intake in the rat. Brain Res Bull 28: 299–303
Ahluwalia A, Giuliani S, Maggi CA (1995) Demonstration of a’ septide-sensitive’ inflammatory response in rat skin. Br J Pharmacol 116: 2170–2174
Anderson WG, Conlon JM, Hazon N (1995) Characterization of the endogenous intestinal peptide that stimulates the rectal gland of Scyliorhinus canicula. Am J Physiol 268: R1359–R1364
Arai H, Emson PC (1986) Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system. Brain Res 399: 240–249
Badgery-Parker T, Lovas S, Conlon JM, Burcher E (1993) Receptor binding profile of neuropeptide γ and its fragments: comparison with the non-mammalian peptides carassin and ranakinin at three mammalian tachykinin receptors. Peptides 14: 771–776
Balks HJ, Conlon JM, Creutzfeldt W, Stockmann F (1989) Effect of a long-acting analogue (Octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush. Eur J Clin Pharmacol 36: 133–137
Beaujouan J, Torrens C, Viger A, Glowinski J (1984) A new type of tachykinin binding site in the rat brain characterized bγspecific binding of a labeled eledoisin derivative. Mol Pharmacol 26: 248–254
Beaujouan JC, Saffroy M, Torrens Y, Sagan S, Glowinski J (1999) Pharmacological characterization of tachykinin septide-sensitive binding sites in the rat submaxillary gland. Peptides 20: 1347–1352
Bellucci F, Carini F, Catalani C, Cucchi P, Lecci A, Meini S, Patacchini R, Quartara L, Ricci R, Tramontana M, Giuliani S, Maggi CA (2002) Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. Br J Pharmacol 135: 266–274
Bonner TI, Affolter H-U, Young AC, Young WS (1987) A cDNA encoding the precursor of the rat neuropeptide, neurokinin B. Mol Brain Res 2: 243–249
Bristow LJ, Young L (1994) Chromo dacryorrhea and repetitive hind paw tapping: models of peripheral and central tachykinin NK1 receptor activation in gerbils. Eur J Pharmacol 253: 245–252
Broccardo M, Improta G, Tabacco A (1999) Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII. Eur J Pharmacol 376: 67–71
Buck SH, Krstenansky JL (1987) The dogfish peptides scyliorhinin I and scyliorhinin II bind with differential selectivity to mammalian tachykinin receptors. Eur J Pharmacol 144: 109–111
Burcher E, Stamatakos C (1994) Septide but not substance P stimulates inhibitory neurons in guinea-pig ileum. Eur J Pharmacol 258: R9–10
Burcher E, Alouan LA, Johnson PR, Black JL (1991) Neuropeptide γ, the most potent contractile tachykinin in human isolated bronchus, acts via a ‘non-classical’ NK2 receptor. Neuropeptides 20: 79–82
Burcher E, Badgery-Parker T, Zeng X-P, Lavielle S (1993) Characterisation of a novel, selective radioligand, [125I]Lys5,Tyr(I2)7,MetLeu9,Nle10]neurokinin A(4–10) for the tachykinin NK-2 receptor in rat fundus. Eur J Pharmacol 233: 201–207
Carter MS, Krause JE (1990) Structure, expression, and some regulatory mechanisms of the rat preprotachykinin gene encoding substance P, neurokinin A, neuropeptide K, and neuropeptide γ. J Neurosci 10: 2203–2214
Camarda V, Rizzi A, Calo G, Guerrini R, Salvadori S, Regoli D (2002) Pharmacological profile of hemokinin 1: a novel member of the tachykinin family. Life Sci 71: 363–370
Casasco A, Calligaro A, Springall DR, Casasco M, Poggi P, Valentino KI, Polak JM (1990) Neuropeptide K in human dental pulp. Arch Oral Biol 35: 33–36
Cascieri MA, Huang RRC, Fong TM, Cheung AH, Sadowski S, Ber E, Strader CD (1992) Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors. Mol Pharmacol 41: 1096–1099
Cellier E, Barbot L, Iyengar S, Couture R (1999) Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat. Br J Pharmacol 127: 717–728
Chang MM, Leeman SE (1971) Isolation of a sialogogic peptide from bovine hypothalamic tissue and its characterization as substance P. J Biol Chem 245: 4784–4790
Chassaing G, Lavielle S, Locuillet D, Robilliard P, Carruette A, Garret C, Beaujouan J-C, Saffroy M, Petitet F, Torrens Y, Glowinski J (1991) Selective agonists of NK-2 binding sites highly active on rat portal vein (NK-3 bioassay). Neuropeptides 19: 91–95
Ciucci A, Palma C, Manzini S, Werge TM (1998) Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and Band septide. Br J Pharmacol 125: 393–401
Comis A, Burcher E (1999) Structure-activity studies at the rat tachykinin NK2 receptor: effect of substitution at position 5 of neurokinin A. J Pept Res 53: 337–342
Conlon JM (1991) Measurement of neurokinin B by radioimmunoassay. In: Conn PM (ed) Methods in Neurosciences, Vol 6. Academic Press, San Diego, pp 221–231
Conlon JM, Goke B (1984) Metabolism of substance P in human plasma and in the rat circulation. J Chromatogr 296: 241–247
Conlon JM, Sheehan L (1983) Conversion of substance P to C-terminal fragments in human plasma. Regul Pept 7: 335–345
Conlon JM, Schafer G, Schmidt WE, Lazarus LH, Becker HD, Creutzfeldt W (1985) Chemical and immunochemical characterization of substance P-like immunoreactivity and physalaemin-like immunoreactivity in a carcinoid tumour. Regul Pept 11: 117–132
Conlon JM, Deacon CF, O’Toole L, Thim L (1986) Scyliorhinin I and II, two novel tachykinins from dogfish gut. FEBS Lett 200: 111–116
Conlon JM, Deacon CF, Richter G, Stockmann F, Creutzfeldt W (1987) Circulating tachykinins (substance P, Neurokinin A, neuropeptide K) and the carcinoid flush. Scand J Gastroenterol 22: 97–105
Conlon JM, Deacon CF, Grimelius L, Cedermark B, Murphy RF, Thim L, Creutzfeldt W (1988a) Neuropeptide K-(1-24)-peptide: storage and release by carcinoid tumours. Peptides 9: 859–866
Conlon JM, Katsoulis S, Schmidt WE, Thim L (1988b) [Arg3]substance P and neurokinin A from chicken small intestine. Regul Pept 20: 171–180
Conlon JM, O’Harte F, Peter RE, Kah O (1991) Carassin: a tachykinin related to neuropeptide gamma from the brain of the goldfish. J Neurochem 56: 1432–1436
Conlon JM, Adrian TE, Secor SM (1997) Tachykinins (substance P, neurokinin A and neuropeptide γ) and neurotensin from the intestine of the Burmese python, Python molurus. Peptides 18: 1505–1510
Conlon JM, Warner FJ, Burcher E (1998) Bufokinin: a substance P-related peptide from the gut of the toad, Bufo marinus with high binding affinity but low selectivity for mammalian tachykinin receptors. J Peptide Res 51: 210–215
Couture R, Fournier A, Magnan J, St-Pierre S, Regoli D (1979) Structure-activity studies on substance P. Can J Physiol Pharmacol 57: 1427–1436
Couture R, Laneuville O, Guimond C, Drapeau G, Regoli D (1989) Characterization of the peripheral action of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system. Naunyn Schmiedeberg’s Arch Pharmacol 340: 547–557
Cridland RA, Henry JL (1988) N-and C-terminal fragments of substance P: spinal effects in the rat tail flick test. Brain Res Bull 20: 429–432
Dam TV, Takeda Y, Krause JE, Escher E, Quirion R (1990) γ-Preprotachykinin-(72-920-peptide amide: an endogenous preprotachykinin I gene-derived peptide that preferentially binds to neurokinin-2 receptors. Proc Natl Acad Sci USA 87: 246–250
Daoui S, Naline E, Lagente V, Emonds-Alt X, Advenier C (2000) Neurokinin B-and specific tachykinin NK3 receptor agonists-induced airway hyperresponsiveness in the guinea-pig. Br J Pharmacol 130: 49–56
Daoui S, Ahnaou A, Naline E, Emonds-Alt X, Lagente V, Advenier C (2001) Tachykinin NK3 receptor agonists induced microvascular leakage hypersensitivity in the guineapig airways. Eur J Pharmacol 433: 199–207
Decarie A, Couture R (1992) Characterization of the peripheral action of neuropeptide K on the rat cardiovascular system. Eur J Pharmacol 213: 125–131
Deacon CF, Agoston DV, Nau R, Conlon JM (1987) Conversion of neuropeptide K to neurokinin A and vesicular colocalization of neurokinin A and substance P in neurons of the guinea pig small intestine. J Neurochem 48: 141–146
Debeljuk L, Rettori V, Bartke A, McCann S (1995) In vivo and in vitro effects of neuropeptide K and neuropeptide γ on the release of growth hormone. Neuroreport 6: 2457–2460
Debeljuk L, Lasaga M (1999) Modulation of the hypothalmo-pituitary-gonadal axis and the pineal gland by neurokinin A, neuropeptide K and neuropeptide γ. Peptides 20: 285–299
DeVane CL (2001) Substance P: a new era, a new role. Pharmacotherapy 21: 1061–1069
Dion S, Corcos J, Carmel M, Drapeau G, Regoli D (1988) Substance P and neurokinins as stimulants of the human isolated urinary bladder. Neuropeptides 11: 83–87
Dion S, Rouissi N, Nantel F, Drapeau G, Regoli D, Naline E, Advenier C (1990) Receptors for neurokinins in human bronchus and urinary bladder are of the NK-2 type. Eur J Pharmacol 178: 215–219
D’Orleans-Iuste P, Claing A, Telemaque S, Warner TD, Regoli D (1991) Neurokinins produce selective venoconstriction via NK-3 receptors in the rat mesenteric vascular bed. Eur J Pharmacol 12: 329–334
Drapeau G, D’Orleans-Iuste P, Dion S, Rhaleb NE, Regoli D (1987a) Selective agonists for neurokinin B receptors. Eur J Pharmacol 136: 401–403
Drapeau G, D’Orleans-Iuste P, Dion S, Rhaleb NE, Rouissi NE, Regoli D (1987b) Selective agonists for substance P and neurokinin receptors. Neuropeptides 10: 43–54
Duplaa H, Chassaing G, Lavielle S, Beaujouan JC, Torrens Y, Saffroy M, Glowinski J, D’Orieans Iuste P, Regoli D, Carruette A et al. (1991) Influence of the replacement of amino acid by its D-enantiomer in the sequence of substance P. 1. Binding and pharmacological data. Neuropeptides 19: 251–257
Erspamer V, Anastasi A (1962) Structure and pharmacological actions of eledoisin, the active endecapeptide of the posterior salivary glands of Eledone. Experientia 18: 58–59
Evangelista S, Lippe IT, Rovero P, Maggi CA, Meli A (1989) Tachykinins protect against ethanol-induced gastric lesions in rats. Peptides 10: 79–81
Figini M, Emanueli C, Bertrand C, Iavdan P, Geppetti P (1996) Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septideinsensitive NK1 receptor. Br J Pharmacol 117: 1270–1276
Fisher L, Pennefather JN (1998) Structure-activity atudies of analogues of neurokinin A mediating contraction of rat uterus. Neuropeptides 32: 405–410
Flood JF, Baker ML, Hernandez EN, Morley JE (1990) Modulation of memory retention by neuropeptide K. Brain Res 520: 284–290
Floch A, Fardin V, Cavero I (1994) Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems. Br J Pharmacol 111: 759–768
Floch A, Thiry C, Cavero I (1996) Pharmacological evidence that NK-2 tachykinin receptors mediate hypotension in the guinea pig but not in the rat. Fundam Clin Pharmacol 10: 337–343
Frossard N, Advenier C (1991) Tachykinin receptors and the airways. Life Sci 49: 19411953
Garcia-Fernandez J, Holland PWH (1994) Archetypal organization of the amphioxus Hox gene cluster. Nature 370: 563–566
Grant AD, Akhtar R, Gerard NP, Brain SD (2002) Neurokinin B induces oedema formation in mouse lung via tachykinin receptor independent mechanisms. J Physiol 543: 1007–1014
Guard S, Watson SP, Maggio JE, Too HP, Watling KJ (1990) Pharmacological analysis of [3H]-senktide binding to NK3 tachykinin receptors in guinea-pig ileum longitudinal muscle-myenteric plexus and cerebral cortex membranes. Br J Pharmacol 99: 767–773
Hagan RM, Ireland SJ, Jordan CC, Beresford IJ, deal MJ, Ward P (1991) Receptor-selective, peptidase-resistant agonists at neurokinin NK-l and NK-2 receptors: new tools for investigating neurokinin function. Neuropeptides 19: 127–135
Hagio T, Takano Y, Nagashima A, Nakayama Y, Tateishi K, Kamiya H (1991) The central pressor actions of a novel tachykinin peptide, y-preprotachykinin-(72-92)-peptide amide Eur J Pharmacol 192: 173–176
Hall JM, Morton IK (1991) Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens. Br J Pharmacol 102: 511–517
Hall ME, Stewart JM (1984) Modulation of isolation-induced fighting by N-and C-terminal analogs of substance P: evidence for multiple recognition sites. Peptides 5: 85–89
Hall ME, Stewart JM (1992) The substance P fragment SP(1–7) stimulates motor behavior and nigral dopamine release. Pharmacol Biochem Behav 41: 75–78
Hall ME, Miley F, Stewart JM (1989a) Cardiovascular effects of substance P peptides in the nucleus of the solitary tract. Brain Res 497: 280–290
Hall ME, Miley F, Stewart JM (1989b) The role of enzymatic processing in the biological actions of substance P. Peptides 10: 895–901
Harmar AJ, Armstrong A, Pascali JC, Chapman K, Rosie R, Curtis A, Going J, Edwards CRW, Fink G (1986) cDNA sequence of human, B-preprotachykinin, the common precursor to substance P and neurokinin A. FEBS Lett 208: 67–72
Harmar AJ, Hyde V, Chapman K (1990) Identification and cDNA sequence of δ-preprotachykinin, a fourth splicing variant of the rat substance P precursor. FEBS Lett 275: 22–24
Harrison S, Geppetti P (2001) Substance P. Int J Biochem Cell Biol 33: 555–576
Hastrup H, Schwartz TW (1996) Septide and neurokinin A are high-affinity ligands on the NK-1 receptor: evidence from homologous versus heterologous binding analysis. FEBS Lett 399: 264–266
Herrera-Marschitz M, Terenius L, Sakurada T, Reid MS, Ungerstedt U (1990) The substance P(1-7) fragment is a potent modulator of substance P actions in the brain. Brain Res 521: 316–20
Hokfelt T, Pernow B, Wahren J (2001) Substance P: a pioneer amongst neuropeptides. J Intern Med 249: 27–40
Holzer P, Holzer-Petsche U (1997a) Tachykinins in the gut. I. Expression, release and motor function. Pharm Ther 73: 173–217
Holzer P, Holzer-Petsche U (1997b) Tachykinins in the gut. II. Roles in neural excitation, secretion and inflammation. Pharm Ther 73: 219–263
Holzer P, Sametz W (1986) Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin-sensitive afferent neurons. Gastroenterology 91: 975–981
Hua XY, Theodorsson-Norheim E, Brodin E, Lundberg JM, Hökfelt T (1985) Multiple tachykinins (neurokinin A, neuropeptide K and substance P) in capsaicin-sensitive sensory neurons in the guinea-pig. Regul Pept 13: 1–19
Hughes AL (1999) Phylogenies of developmentally important proteins do not support the hypothesis of two rounds of genome duplication early in vertebrate history. J Mol Evol 48: 565–576
Huston JP, Hasenohrl RU (1995) The role of neuropeptides in learning: focus on the neurokinin substance P. Behav Brain Res 23: 117–27
Igwe OJ, Kim DC, Seybold VS, Larson AA (1990) Specific binding of substance P aminoterminal heptapeptide [SP(1-7)] to mouse brain and spinal cord membranes. J Neurosci 10: 3653–3663
Improta G, Broccardo M (1991) Inhibitory role on gastric secretion of a central NK-3 tachykinin receptor agonist, senktide. Peptides 12: 1433–1434
Improta G, Broccardo M (2000) Effects of supraspinal administration of PG-SPI and PGKII, two amph ibian tachykinin peptides, on nociception in the rat. Peptides 21: 1611–1616
Improta G, Broccardo M, Severini C, Erspamer V (1996) In vitro and in vivo biological activities of PG-KII, a novel kassinin-like peptide from the skin of the Australian frog, Pseudophryne guntheri. Peptides 17: 1003–1008
Improta G, Broccardo M, Tabacco A, Evangelista S (1997) Central and peripheral antiulcer and antisecretory effects of [Ala5]NKA(4–10), a tachykinin receptor agonist, in rats. Neuropeptides 31: 399–402
Itoi K, Tschope C, lost N, Culman J, Lebrun C, Stauss B, Unger T (1992) Identificat ion of the central tachykin in receptor subclass involved in substance P-induced cardiovascular and behavioral responses in conscious rats. Eur J Pharmacol 219: 435–444
Jansen I, Alafaci C, McCulloch J, Uddman R, Edvinsson L (1991) Tachykinins (substance P, neurokinin A, neuropeptide K, and neurokinin B) in the cerebral circulation: vasomotor responses in vitro and in vivo. J Cereb Blood Flow Metab 11: 567–575
Jensen J, Conlon JM (1992) Substance P-related and neurokinin A-related peptides from the brain of the cod and trout. Eur J Biochem 206: 659–664
Jensen J, Olson KR, Conlon JM (1993) Primary structures and effects on gastrointestinal motility of tachykinins from the rainbow trout. Am J Physiol 265: R804–R810
Johansson A, Holmgren S, Conlon JM (2002) The primary structures and myotropic activities of two tachykinins isolated from the African clawed frog, Xenopus laevis. Regul Pept 108: 113–121
Jones RS, Olpe HR (1982) A structure-activity profile of substance P and some of its fragments on supraspinal neurones in the rat. Neurosci Lett 33: 67–7 1
Kage R, Conlon JM (1989) Neurokinin B in a human pheochromocytoma measured with a specific radioimmunoassay. Peptides 10: 713–716.
Kage R, McGregor GP, Thim L, Conlon JM (1988). Neuropeptide γ: a peptide isolated from rabbit intestine that is derived from gamma-preprotachykinin. J Neurochem 50: 1412–1417
Kågström J, Holmgren S, Olson KR, Conlon JM, Jensen J (1996) Vasoconstrictive effects of native tachykinins in the rainbow trout, Oncorhynchus mykiss. Peptides 17: 39–45
Kako K, Munekata E, Hosaka M, Murakami K, Nakayama K (1993) Cloning and sequence analysis of mouse cDNAs encoding preprotachykinin A and B. Biomed Res 14: 253–259
Kalra PS, Kalra SP (1993) Neuropeptide K stimulates corticosterone release in the rat. Brain Res 610: 330–333
Kalra P, Sahu A, Bonavera J, Kalra S (1992) Diverse effects of tachykinins on luteinizing hormone release in male rats: mechanism of action. Endocrinology 131: 1195–1201
Kalra SP, Dube MG, Kalra PS (1991) Neuropeptide K (NPK) suppresses copulatory behavior in male rats. Physiol Behav 49: 1297–1300
Kangawa K, Minamino N, Fukuda A, Matsuo H (1983) Neuromedin K: a novel mammalian tachykinin identified in porcine spinal cord. Biochem Biophys Res Commun 114: 533–540
Karagiannis K, Manolopoulou A, Stavropoulos G, Poulos C, Jordan CC, Hagan RM (1991) Synthesis of a potent agonist of substance P by modifying the methionyl and glutaminyl residues of the C-terminal hexapeptide of substance P. Structure-activity relationships. Int J Pept Protein Res 38: 350–356
Kawaguchi Y, Hoshimaru M, Nawa H, Nakanishi S (1986) Sequence analysis of cloned cDNA for rat substance P precursor. Biochem Biophys Res Commun 139: 1040–1046
Khan I, Collins SM (1994) Fourth isoform of preprotachykinin messenger RNA encoding for substance P in the rat intestine. Biochem Biophys Res Commun 202: 796–802
Kimura S, Okada M, Sugita Y, Kanazawa I, Munekata E (1983) Novel neuropeptides, neurokinins α and β, isolated from porcine spinal cord. Proc Jpn Acad Ser B 59: 101–104
Kishimoto S, Tateishi K, Kobayashi H, Kobuke K, Hagio T, Matsuoka Y, Kajiyama G, Miyoshi A (1991) Distribution of neurokinin A-like and neurokinin B-like immunoreactivity in human peripheral tissues. Regul Pept 36: 165–171
Kodjo MK, Leboulenger F, Conlon JM, Vaudry H (1995a) Effect of ranakinin, a novel tachykinin, on cytosolic free calcium in frog adrenochromaffin cells. Endocrinology 136: 4535–4542
Kodjo MK, Leboulenger F, Porcedda P, Lamacz M, Conlon JM, Pelletier G, Vaudry H (1995b) Evidence for the involvement of chromaffin cells in the stimulatory effect of tachykinins on corticosteroid secretion by the frog adrenal gland. Endocrinology 136: 3253–3259
Kodjo MK, Leboulenger F, Morra M, Conlon JM, Vaudry H. (1996) Pharmacological profile of the tachykinin receptor involved in the stimulation of corticosteroid secretion in the frog Rana ridibunda. J Steroid Biochem Mol Biol 57: 329–335
Kotani H, Hoshimaru M, Nawa H, Nakanishi S (1986) Structure and gene organization of the bovine neuromedin K precursor. Proc Natl Acad Sci USA 83: 7074–7078
Kozawa H, Hino J, Minamino N, Kangawa K, Matsuo H (1991) Isolation of four novel tachykinins from frog (Rana catesbeiana) bra in and intetine. Biochem Biophys Res Commun 177: 588–595
Krause JE, Chirgwin JM, Carter MS, Xu ZS, Hershey AD (1987) Three rat preprotachykinin mRNAs encode the neuropeptides, substance P and neurokinin A. Proc Natl Acad Sci USA 84: 881–885
Kreeger JS, Larson AA (1996) The substance P amino-terminal metabolite substance P(1–7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice. J Pharmacol Exp Ther 279: 662–667
Kurtz M, Wang R, Clements M, Cascieri M, Austin C, Cunningham B, Chicchi G, Liu Q (2002) Identification, localization and receptor characterization of novel mammalian substance P-like peptides. Gene 296: 205–212
Laneuville O, Dorais J, Couture R (1998) Characterization of the effects produced by neurokinins and three agonists selective for neurokinin receptor subtypes in a spinal nociceptive reflex of the rat. Life Sci 42: 1295–1305
Larhammar D, Lundin LG, Hallbook F (2002) The human Hox-bearing chromosome regions did arise by block or chromosome (or even genome) duplications. Genome Res 12: 1910–1920
Larson AA, Sun X (1992) Amino terminus of substance P potentiates kainic acid-induced activity in the mouse spinal cord. J Neurosci 12: 4905–4910
Lavielle S, Chassaing G, Besseyre J, Marquet A, Bergstrom L, Beaujouan JC, Torrens Y, Glowinski J (1986a) A cyclic analogue selective for the NKB specific binding site on rat brain synaptosomes. Eur J Pharmacol 128: 283–285
Lavielle S, Chassaing G, Julien S, Marquet A, Bergstrom L, Beaujouan JC, Torrens Y, Glowinski J (1986b) Specific recognition of SP or NKB receptors by analogs of SP substituted at positions 8 and 9. Eur J Pharmacol 125: 461–462
Lavielle S, Chassaing G, Loeuillet D, Convert O, Torrens Y, Beaujouan JC, Saffroy M, Petitet F, Bergstrom L, Glowinski J (1990) Selective agonists of tachykinin binding sites. Fundam Clin Pharmacol 4: 257–268
Lavielle S, Chassaing G, Brunissen A, Rodriguez M, Martinez J, Convert O, Carruette A, Garret C, Petitet F, Saffroy M (1993) Importance of the leucine side-chain to the spas mogenic activity and binding of substance P analogues. Int J Pept Protein Res 42: 270–277
Leboulenger F, Vaglini L, Conlon JM, Homo-Delarche F, Wang Y, Kerdelhue B, Pelletier G, Vaudry H (1993) Immunohistochemical distribution, biochemical characterization, and biological action of tachykinins in the frog adrenal gland. Endocrinology 133: 1999–2008
Lecci A, Maggi CA (2001) Tachykinins as modulators of the micturition reflex in the central and peripheral nervous system. Regul Pept 101: 1–18
Lecci A, Giulani S, Tramontana M, Carini F, Maggi CA (2000) Peripheral actions of tachykinins. Neuropeptides 34: 303–313
Lew R, Geraghty DP, Drapeau G, Regoli D, Burcher E (1990) Binding characteristics of [125I]Boiton-Hunter [Sar9,Met(O2)11]substance P, a new selective radioligand for the NK1 receptor. Eur J Pharmacol 184:97–108
Lin XW, Peter RE (1997) Goldfish gamma-preprotachykinin mRNA encodes the neuropeptides substance P, carassin, and neurokinin A. Peptides 18: 817–824
Linari G, Broccardo M, Nucerito V, Irnprota G (2002) Selective tachykinin NK3-receptor agonists stimulate in vitro exocrine pancreatic secretion in the guinea pig. Peptides 23: 947–953
Liu L, Warner FJ, Conlon JM, Burcher E (1999) Pharmacological and biochemical investigation of receptors for the toad gut tachykinin peptide, bufokinin, in its species of origin. Naunyn Schmiedeberg’s Arch Pharmacol 360: 187–195
Liu L, Shang F, Comis A, Burcher E (2000) Bufokinin: act ions and distribution in the toad cardiovascular system. Clin Exp Pharmacol Physiol 27: 911–916
Lundin LG (1993) Evolution of the vertebrate genome as reflected in paralogous chromosomal regions in man and the house mouse. Genomics 16: 1–19
Magert HJ, Heitland A, Rose M, Forssmann WG (1993) Nucleotide sequence of the rabbit gamma-preprotachykinin I cDNA. Biochem Biophys Res Commun 195: 128–131
Maggi CA, Patacchini R, Santicioli P, Giuliani S, Turini D, Barbanti G, Giachetti A, Meli A (1989) Human isolated ileum: motor responses of the circular muscle to electrical field stimulation and exogenous neuropeptides. Naunyn Schmiedebergs Arch Pharmacol 341: 256–261
Maggi CA, Giuliani S, Ballati L, Rovero P, Abelli L, Manzini S, Giachetti A, Meli A (1990a) In vivo pharmacology of [βAla8]neurokinin A-(4–10), a selective NK-2 tachykinin receptor agonist. Eur J Pharmacol 177: 81–86
Maggi CA, Patacchini R, Santicioli P, Giuliani S, Turini D, Barbanti G, Beneforti P, Misuri D, Meli A (1990b) Human isolated small intestine: motor responses of the longitudinal muscle to field stimulation and exogenous neuropeptides. Naunyn Schmiedebergs Arch Pharmacol 339: 415–423
Makridis C, Theodorsson E, Akerstrom G, Oberg K, Knutson L (1999) Increased intestinal non-substance P tachykinin concentrations in malignant midgut carcinoid disease. J Gastroenterol Hepatol 14: 500–507
Martling C-R, Theodorsson-Norheim E, Lundberg JM (1987a) Occurrence and effects of multiple tachykinins; substance P, neurokinin A and neuropeptide K in human lower airways. Life Sci 40: 1633–1643
Martling C-R, Theodorsson-Norheim E, Norheim I, Lundberg JM (1987b) Bronchoconstrictor and hypotensive effects in relation to pharmokinetics in the guinea-pig-evidence for extraneuronal cleavage of neuropeptide K to neurokinin A. NauynSchrniedeberg’s Arch Pharmacol 336: 183–189
Matuszek MA, Comis A, Burcher E (1999) Binding and functional potency of neurokinin A analogues in the rat fundus: a structure-activity study. Pharmacology 58: 227–235
McGregor GP, Gaedicke G, Voigt K (1990) Neurokinin-immunoreactivity in human neuroblastomas. Evidence for selective expression of the preprotachykinin (PPT) II gene. FEBS Lett 277: 83–87
McRoberts JA, Coutinho SV, Marvizon JC, Grady EF, Tognetto M, Sengupta JN, Ennes HS, Chaban VV, Amadesi S, Creminon C, Lanthorn T, Geppetti P, Bunnett NW, Mayer EA (2001) Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology 120: 1737–1748
Michael-Titus AT, Blackburn D, Connolly Y, Priestley JV, Whelpton R (1999) N-and C-terminal substance P fragments: differential effects on striatal [3H]substance P binding and NK]1receptor internalization. Neuroreport 10: 2209–2213
Michael-Titus AT, Fernandes K, Setty H, Whelpton R (2002) In vivo metabolism and clearance of substance P and co-expressed tachykinins in rat striatum. Neuroscience 110: 277–286
Minamino N, Kangawa K, Fukuda A, Matsuo H (1984) Neuromedin L: a novel mammalian tachykinin identified in porcine spinal cord. Neuropeptides 4: 157–166
Mousseau DD, Sun X, Larson AA (1994) An antinociceptive effect of capsaicin in the adult mouse mediated by the NH2-terminus of substance P. J Pharmacol Exp Ther 268: 785–790
Mussap CJ, Burcher E (1990) [125I]-Bolton-Hunter scyliorhinin II: a novel, selective radioligand for the tachykinin NK3receptor in rat brain. Peptides 11: 827–836
Nau R, Schafer G, Deacon CF, Cole T, Conlon JM (1986) Proteolytic inactivation of substance P and neurokinin A in the longitudinal muscle layer of the guinea small intestine. J Neurochem 47: 856–864
Nawa H, Kotani H, Nakanishi S (1984) Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing. Nature 312: 729–734
Nguyen-Le XK, Nguyen QT, Gobeil F, Jukic D, Chretein L, Regoli D (1996) Neurokinin receptors in the guinea pig ileum. Pharmacology 52: 35–45
Nikolaus S, Huston JP, Hasenohrl RU (2000) Anxiolytic-like effects in rats produced by ventral pallidal injection of both N-and C-terminal fragments of substance P. Neurosci Lett 283: 37–40
Norheim I, Theodorsson-Norheim E, Brodin E, Oberg K (1986) Tachykinins in carcinoid tumors: their use as a tumor marker and possible role in the carcinoid flush. J Clin Endocrinol Metab 63: 605–612
O’Harte F, Burcher E, Lovas S, Smith DD, Vaudry H, Conlon JM (1991) Ranakinin: a novel NK1 tachykinin receptor agonist isolated with neurokinin B from the brain of the frog, Rana ridibunda. J Neurochem 57: 2086–2091
Page NM, Bell, NJ, Gardiner SM, Manyonda IT, Brayley KJ, Strange PG, Lowry PJ (2003) Characterization of the endokinins: human tachykinins with cardiovascular activity. Proc Natl Acad Sci USA 100: 6245–6250
Page NM, Woods RJ, Gardiner SM, Lomthaisong K, Gladwell RT, Butin DJ, Manyonda IT, Lowry PJ (2000) Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature 405: 797–800
Page NM, Woods RJ, Lowry PJ (2001) A regulatory role for neurokinin B in placental physiology and pre-eclampsia. Regul Pept 98: 97–104
Patacchini R, Quartara L, Rovero P, Goso C, Maggi CA (1993) Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties. J Pharmacol Exp Ther 264: 17–21
Patacchini R, Bartho L, Maggi CA (1997) Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct. Br J Pharmacol 122: 1633–1638
Petitet F, Beaujouan J-C, Saffroy M, Torrens Y, Chassaing G, Lavielle S, Besseyre J, Garret C, Curruette A, Glowinski J (1991) Further demonstration that [Pro9]-substance P is a potent and selective ligand of NK-1 tachykinin receptors. J Neurochem 56: 879–889
Petitet F, Saffroy M, Torrens Y, Lavielle S, Chassaing G, Loeuillet D, Glowinski J, Beaujouan JC (1992) Possible existence of a new tachykinin receptor subtype in the guinea pig ileum. Peptides 13: 383–838
Picard P, Couture R (1996) Intracerebroventricular responses to neuropeptide γ in the conscious rat: characterization of its receptor with selective antagonists. Br J Pharmacol 117: 241–249
Pinto FM, Cintado CG, Devillier P, Candenas ML (2001) Expression of preprotachykinin-B, the gene that encodes neurokinin B, in the rat uterus. Eur J Pharmacol 425: R1–R2
Piot O, Betschart J, Grall I, Ravard S, Garret C, Blanchard JC (1995) Comparative behavioural profile of centrally administered tachykinin NK1 NK2 and NK3 receptor agonists in the guinea-pig. Br J Pharmacol 116: 2496–2502
Ploux O, Lavielle S, Chassaing G, Julien S, Marquet A, d’Orleans-Iuste P, Dion S, Regoli D, Beaujouan JC, Bergstrom L et al. (1987) Interaction of tachykinins with their receptors studied with cyclic analogues of substance P and neurokinin B. Proc Natl Acad Sci USA 84: 8095–8099
Polidori C, Staffinati G, Perfumi MC, de Caro G, Massi M (1995) Neurop eptide y: a mammalian tachykinin endowed with potent antidipsogenic action in rats. Physiol Behav 58: 595–602
Poulat P, de Champlain J, Couture R (1996) Cardiovascular responses to intrathecal neuropeptide γ in conscious rats: receptor characterization and mechanism of action. Br J Pharmacol 117: 250–257
Poulos C, Stavropoulos G, Brown JR, Jordan CC (1987) Structure-activity studies on the C-terminal hexapeptide of substance P with modifications at the glutaminyl and methioninyl residues. J Med Chem 30: 1512–1525
Pradier L, Menager J, Le Guern J, Bock MD, Heuillet E, Fardin V, Garret C, Doble A, Mayaux JF (1994) Septide: an agonist for the NK1 receptor acting at a site distinct from substance P. Mol Pharmacol 45: 287–293
Prat A, Picard P, Couture R (1994) Cardiovascular and behavioural effects of centrally administered neuropeptide K in the rat: receptor characterization. Br J Pharmacol 112: 250–256
Qian Y, Advenier C, Naline E, Bellamy JF, Emonds-Alt X (1994) Effects of SR 48968 on the neuropeptide y-induced contraction of the human isolated bronchus. Fundam Clin Pharmacol 8: 71–75
Quartara L, Maggi CA (1997) The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation. Neuropeptides 31: 537–563
Quartara L, Maggi CA (1998) The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles. Neuropeptides 32: 1–49
Rahman M, Lordal M, al-Saffar A, Hellstrom PM (1994) Intestinal motility responses to neuropeptide γ in vitro and in vivo in the rat: comparison with neurokinin 1 and neurokinin 2 receptor agonists. Acta Physiol Scand 151: 497–505
Ravard S, Betschart J, Fardin V, Flamand O, Blanchard JC (1994) Differential ability of tachykinin NK-1 and NK-2 agonists to produce scratching and grooming behaviours in mice. Brain Res 651: 199–208
Regoli D, Mizrahi J, D’Orieans-Juste P, Escher E (1984) Receptors for substance P. II. Classification by agonist fragments and homologues. Eur J Pharmacol 97: 171–177
Ribeiro SJ, Teixeira RM, Calixto JB, de Lima TC (1999) Tachykinin NK3 receptor involvement in anxiety. Neuropeptides 33: 181–188
Rivera Baeza C, Unden A (1991) Investigation of the importance of the N-terminal peptide bonds of substance P by synthetic pseudopeptide analogs. Neuropeptides 20: 83–86
Roth KA, Makk G, Beck O, Faull K, Tatemoto K, Evans CT, Barchas JD (1985) Isolation and characterization of substance P, substance P 5–11, and substance K from two metastatic ileal carcinoids. Regul Pept 12: 185–199
Rovero P, Pestellinin V, Rhaleb N-E, Dion S, Rouissi N, Tousignant C, Telemaque S, Drapeau G, Regoli D (1989) Structure-activity studies of neurokinin A. Neuropeptides 13: 263–270
Sachon E, Girault-Lagrange S, Chassaing G, Lavielle S, Sagan S (2002) Analogs of substance P modified at the C-terminus which are both agonist and antagonist of the NK-1 receptor depending on the second messenger pathway. J Pept Res 59: 232–240
Saffroy M, Torrens Y, Glowinski J, Beaujouan JC (2001) Presence of NK2 binding sites in the rat brain. J Neurochem 79: 985–996
Sagan S, Beaujouan JC, Torrens Y, Saffroy M, Chassaing G, Glowinski J, Lavielle S (1997) High affinity binding of [3H]propionyl-[Met(O2)11]substance P(7–11), a tritiated septide-like peptide, in Chinese hamster ovary cells expressing human neurokinin-1 receptors and in rat submandibular glands. Mol Pharmacol 52: 120–127
Sagan S, Karoyan P, Chassaing G, Lavielle S (1999) Further delineation of the two binding sites (R*(n)) associated with tachykinin neurokinin-1 receptors using [3-Prolinomethionine(11))SP analogues. J Biol Chem 274: 23770–23776
Sagan S, Milcent T, Ponsinet R, Convert O, Tasseau O, Chassaing G, Lavielle S, Lequin O (2003) Structural and biological effects of a beta2-or beta3-amino acid insertion in a peptide. Eur J Biochem 270: 939–949
Sahu A, Kalra S (1992) Effects of tachykinins on luteinizing hormone release in female rats: potent inhibitory action of neuropeptide K. Endocrinology 130: 1571–1577
Sahu A, Kalra PS, Dube MG, Kalra SP (1988) Neuropeptide K suppresses feeding in the rat. Regul Pept 23: 135–143
Sakurada T, Le Greves P, Stewart J, Terenius L (1985) Measurement of substance P metabolites in rat CNS. J Neurochem 44: 718–22
Sakurada T, Tan-No K, Yamada T, Sakurada S, Kisara K, Ohba M, Terenius L (1990) N-terminal substance P fragments inhibit the spinally induced, NK 1 receptor mediated behavioural responses in mice. Life Sci 47: 109–113
Sakurada C, Watanabe C, Inoue M, Tan-No K, Ando R, Kisara K, Sakurada T (1999) Spinal actions of GR73632, a novel tachykinin receptor agonist. Peptides 20: 301–304
Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V (2002) The tachykinin peptide family. Pharmacol Rev 54: 285–322
Sheehan TP, Numan M (1997) Microinject ions of the tachykinin neuropeptide K into the ventromedial hypothalamus disrupts the hormonal onset of maternal behavior in female rats. J Neuroendocrinol 9: 677–687
Shore SA, Sharpless C, Drazen JM (1993) Bronchoconstrictor activities of NP γ and NPK in anaesthetized guinea-pigs: effect on NEP inhibition. Pulm Pharmacol 6: 143–147
Sidow A (1996) Gen(om)e duplications in the evolution of early vertebrates. Curr Opin Genet Dev 6: 715–722
Snijdelaar DG, Dirksen R, Siappendel R, Crul BJ (2000) Substance P. Eur J Pain 4: 121–135
Söderberg C, Wraith A, Rigvall M, Yan YL, Postlethwait JH, Brodin L, Larhammar D (2000) Zebrafish genes for neuropeptide Yand peptide YY reveal origin by chromosome duplication from an ancestral gene linked to the homeobox cluster. J Neurochem 75: 908–918
Stewart JM, Hall ME, Harkins J, Frederickson RC, Terenius L, Hokfelt T, Krivoy WA (1982) A fragment of substance P with specific central activity: SP(1–7). Peptides 3: 851–857
Takeda Y, Krause JE (1989) Neuropeptide K potently stimulates salivary gland secretion and potentiates substance P-induced salivation. Proc Natl Acad Sci USA 86: 392–396
Takeda Y, Takeda J, Smart BM, Krause JE (1990) Regional distribution of neuropeptide γ and other tachykinin peptides derived from the substance P gene in the rat. Regul Pept 28: 323–333
Tateishi K, Matsuoka Y, Hamaoka T (1989) Establishment of highly specific radioimmunoassays for neurokinin A and neurokinin B and determination of tissue distribution of these peptides in rat central nervous system. Regul Pept 24: 245–257
Tateishi K, Kishimoto S, Kobayashi H, Kobuke K, Matsuoka Y (1990) Distribution and localization of neurokinin A-like immunoreactivity and neurokinin B-like immunoreactivity in rat peripheral tissue. Regul Pept 30: 193–200
Tatemoto K, Lundberg JM, Jornvall H, Mutt V (1985) Neuropeptide K: isolation, structure and biological activities of a novel brain tachykinin. Biochim Biophys Res Commun 128: 947–953
Theodorsson-Norheim E, Norheim I, Oberg K, Brodin E, Lundberg JM, Tatemoto K, Lindgren PG (1985) Neuropeptide K: a major tachykinin in plasma and tumor tissues from carcinoid patients. Biochem Biophys Res Commun 131: 77–83
Theodorsson-Norheim E, Jornvall H, Andersson M, Norheim I, Oberg K, Jacobsson G (1987) Isolation and characterization of neurokinin A, neurokinin A(3–10) and neurokinin A(4-10) from a neutral water extract of a metastatic ileal carcinoid tumour. Eur J Biochem 166: 693–697
Too H-P, Cordova JL, Maggio JE (1989) A novel radioimmunoassay for neuromedin K. 1. Absence of neuromedin K-like immunoreactivity in guinea pig ileum and urinary bladder. II. Heterogeneity of tachykinins in guinea pig tissues. Regul Pept 26: 93–105
Toresson G, Brodin E, de las Carreras C, Nordin C, Zachau AC, Bertilsson L (1994) Quantitation of N-terminally extended tachykinins in cerebrospinal fluid from healthy subjects. Regul Pept 24: 185–191
Torrens Y, Beaujouan JC, Saffroy M, Glowinski J (1995) Involvement of septide-sensitive tachykinin receptors in inositol phospholipid hydrolysis in the rat urinary bladder. Peptides 16: 587–594
Tousignant C, Guillemette G, Drapeau G, Telemaque S, Dion S, Regoli D (1990) 125II-BH[Sar9,Met(O2) 11]-SP, a new selective ligand for the NK-I receptor in the central nervous system. Brain Res 524: 263–270
Tschope C, lost N, Unger T, Culman J (1995) Central cardiovascular and behavioral effects of carboxy-and amino-terminal fragments of substance P in conscious rats. Brain Res 690: 15–24
Valentino KL, Tatemoto K, Hunter J, Barchas JD (1986) Distribution of neuropeptide K-immunoreactivity in the rat central nervous system. Peptides 7: 1043–1059
Van Giersbergen PL, Shatzer SA, Burcher E, Buck SH (1992) Comparison of the effects of neuropeptide K and neuropeptide γ with neurokinin A at NK2 receptors in the hamster urinary bladder. Naunyn Schmiedeberg’s Arch Pharmacol 345: 51–56
Velazquez RA, McCarson KE, Cai Y, Kovacs KJ, Shi Q, Evensjo M, Larson AA (2002) Upregulation of neurokinin-1 receptor expression in rat spinal cord by an N-terminal metabolite of substance P. Eur J Neurosci 16: 229–241
Von Euler US, Gaddum JH (1931) An unidentified depressor substance in certain tissue extracts. J Physiol 72: 74–87
Wang Y, Badgery-Parker T, Lovas S, Chartrel N, Vaudry H, Burcher E, Conlon JM (1992a) Primary structure and receptor-binding properties of a neurokinin A-related peptide from frog gut. Biochem J 287: 827–832
Wang Y, O’Harte F, Conlon JM (1992b) Structural characterization of tachykinins (neuropeptide γ, neurokinin A and substance P) from a reptile, Alligator mississipiensis. Gen Comp Endocrinol 88: 277–286.
Wang JX, Dipasquale AJ, Bray AM, Maeji NJ, Spellmeyer DC, Geysen HM (1993a) Systematic study of substance P analogs. II. Rapid screening of 512 substance P stereoisomers for binding to NK1 receptors. Int J Pept Protein Res 42: 392–399
Wang Y, Bockman CS, Lovas S, Abel PW, Murphy RF, Conlon JM (1993b) Neuropeptide γ-(1–9)-peptide: a major product of the post-translational processing of γ-preprotachykinin in rat tissues. J Neurochem 61: 1231–1235
Wang Y, Barton BA, Nielsen PF, Conlon JM (1999a) Tachykinins (substance P and neuropeptide γ) from the brains of the pallid sturgeon, Scaphirhynchus albus and the paddlefish, Polyodon spathula (Acipenseriformes). Gen Comp Endocrinol 116: 21–30
Wang Y, Lance VA, Nielsen PF, Conlon JM (1999b) Neuroendocrine peptides (insulin, pancreatic polypeptide, NPY, galanin, somatostatin, substance P, neuropeptide γ) from the desert tortoise, Gopherus agassizii. Peptides 20: 713–722
Wang T, Axelsson M, Jensen J, Conlon JM (2000) Cardiovascular actions of python bradykinin and substance P in the anesthetized python, Python regius. Am J Physiol 279: R531-R538
Warner FJ, Mack P, Comis A, Miller RC, Burcher E (2001) Structure-activity relationships of neurokinin A(4-10) at the human tachykinin NK2receptor: the role of natural residues and their chirality. Biochem Pharmacol 61: 55–60
Warner FJ, Miller RC, Burcher E (2002) Structure-activity relationships of neurokinin A(4–10) at the human tachykinin NK2 receptor: the effect of amino acid substitutions on receptor affinity and function. Biochem Pharmacol 63: 2181–2186
Watson SP, Sandberg BE, Hanley MR, Iversen LL (1983) Tissue selectivity of substance P alkyl esters: suggesting multiple receptors. Eur J Pharmacol 87: 77–84
Waugh D, Wang Y, Hazon N, Balment RJ, Conlon JM (1993) Primary structures and biological activities of substance P-related peptides from the brain of the dogfish, Scyliorhinus canicula. Eur J Biochem 214: 469–474
Waugh D, Sower S, Bjenning C, Conlon JM (1994) Novel tachykinins from the brain of the sea lamprey, Petromyzon marinus, and the skate, Raja rhina. Peptides 15: 155–161
Waugh D, Bondareva V, Rusakov Y, Bjenning C, Nielsen PF, Conlon JM (1995a) Tachykinins with unusual structural features from a urodele, the amphiuma, an elasmobranch, the hammerhead shark and an agnathan, the river lamprey. Peptides 16: 615–621
Waugh D, Groff KE, Platzack B, Youson JH, Olson KR, Conlon JM (1995b) Isolation, localization and card iovascular activity of tachykinins from the stomach of the bowfin, Amia calva. Am J PhysioI 269: R565–R571
Wijkhuisen A, Sagot MA, Frobert Y, Creminon C, Grassi J, Boquet D, Couraud JY (1999) Identification in the NK1 tachykinin receptor of a domain involved in recognit ion of neurokinin A and septide but not of substance P. FEBS Lett 447: 155–159
Wormser U, Laufer R, Hart Y, Chorev M, Gilon C, Selinger Z (1986) Highly selective agonists for substance P receptor subtypes. EMBOJ 5: 2805–2808
Yuan L, Burcher E, Nail BS (1994) Use of selective agonists and antagonists to characterize tachykinin receptors mediating airway responsiveness in anaesthetized guineapigs. Pulm Pharmacol 7: 169–178
Yuan L, Burcher E, Nail BS (1998) Characterization of tachykinin receptors mediating bronchomotor and vasodepressor responses to neuropeptide gamma and substance P in the anaesthetized rabbit. Pulm Pharmacal Ther 11: 31–39
Yunker AM, Krause JE, Roth KA (1999) Neurokinin B-and substance P-like immunoreactivity are co-localized in enteric nerves of rat ileum. Regul Pept 80: 67–74
Zhang Y, Lu L, Furlonger C, Wu GE, Paige CJ (2000) Hemokinin is a hematopoietic-specific tachykinin that regulates Blymphopoiesis. Nat Immunol 1: 392–397
Zhou Q, Le Greves P, Ragnar F, Nyberg F (2000) Intracerebroventricular injection of the N-terminal substance P fragment SP(1–7) regulates the expression of the N-methylD-aspartate receptor NR1, NR2A and NR2B subunit mRNAs in the rat brain. Neurosci Lett 291: 109–112
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Conlon, J.M. (2004). The Tachykinin Peptide Family, with Particular Emphasis on Mammalian Tachykinins and Tachykinin Receptor Agonists. In: Holzer, P. (eds) Tachykinins. Handbook of Experimental Pharmacology, vol 164. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18891-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-18891-6_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62342-4
Online ISBN: 978-3-642-18891-6
eBook Packages: Springer Book Archive